C A F von Arnim

Author PubWeight™ 8.33^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease.	Neurology	2012	2.23
2	[Short and simple is not always better: limitations of cognitive screening tests].	Fortschr Neurol Psychiatr	2013	1.37
3	Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation.	Exp Neurol	2003	0.82
4	[Maintenance of health and relief for caregivers of elderly with dementia by using "initial case management": experiences from the Lighthouse Project on Dementia, Ulm, ULTDEM-study].	Z Gerontol Geriatr	2012	0.79
5	A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer's disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF.	Eur J Neurol	2009	0.79
6	Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3'-Me-BTA-1 as potential radiotracers for in vivo imaging of beta-amyloid plaques.	Nuklearmedizin	2007	0.78
7	Radiation dosimetry and biodistribution of the beta-amyloid plaque imaging tracer 11C-BTA-1 in humans.	Nuklearmedizin	2007	0.77
8	An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels.	Exp Neurol	2009	0.76
9	[Polyneuropathy and monoclonal IgG/IgA gammopathy--differential neurography on the basis of two patient cases].	Fortschr Neurol Psychiatr	2009	0.75